The Bioresorbable Medical Material in healthcare market was valued at US$ 935.99 million in 2019 and it is projected to reach US$ 1,942.13 million by 2027; it is expected to grow at a CAGR of 9.7% from 2020 to 2027.
Bioresorbable polymers are also known as biodegradable polymers. These are frequently used in implant, drug delivery and other applications. These offer various benefits in medical applications and can be adjusted to degrade at a specified rate, useful for temporary support. The growth of the Bioresorbable Medical Material in healthcare market is attributed to the increasing number of orthopedic surgeries, growing geriatric population and rising adoption of bioresorbable polymers for medical use. However, challenges associated with the use of bioresorbable materials for medical use and bassinet on global business due to coronavirus pandemic are expected to restraint the growth of the market during the forecast years.
The Bioresorbable Medical Material in healthcare market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.
Lucrative Regions for Bioresorbable Medical Material in Healthcare Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Growing Applications of Bioresorbable Medical Material in Healthcare to Drive Bioresorbable Medical Material in Healthcare Market Growth
The rise in ageing population is consequently leading to increase in the total number of orthopedic procedures performed worldwide. In addition, significant advancements in the field of orthopedic science have also helped conduct better and efficient surgical procedures, which is leading to boosting their adoption. With this, the use of biodegradable polymers in the production of bioresorbable implants has also increased. According to a report by Becker’s Hospital (US), the total number of orthopedic surgeries performed in the US is expected to reach 6.6 million in 2020 compared to 5.3 million surgeries performed in 2010. Moreover, according to the American Society of Orthopedic Surgeons (AAOS), a full-time practicing orthopedic surgeon performs ~32 surgeries every month, which averages to more than one surgery performed per day.
The planned orthopedic surgeries also have seen rise in recent years. According to the a review by the Blue Cross Blue Shield Association, medical claims data from 2010 to 2017, showed that the knee and hip replacement surgeries in the US have also increased by 17% and 33%, respectively, from 2010 to 2017. The incorporation of biodegradable implants is also well established in treatment of various sports injuries. As per a survey performed by the American Orthopedic Society for Sports Medicine in 2016, the US reports ~150,000 anterior crucial ligament (ACL) injuries every year, accounting for more than US$ 500 million in the US healthcare costs. Also, the American Academy of Orthopedic Surgeons stated that 126.6 million Americans are suffering with one or more musculoskeletal conditions. Therefore, increasing orthopedic surgeries, coupled with the benefits of bioresorbable medical material in the treatments to musculoskeletal diseases and orthopedic injuries, is likely to boost the demand for bioresorbable medical materials during the forecast period.
According to a study published by the WHO, the world population of people with age 60 and above is expected rise to 2 billion by 2050 to from 900 million in 2015. Moreover, according to the estimates, 80.0% of this population would be residing in emerging countries by 2050. This substantial growth in geriatric population generates demand for highly developed healthcare infrastructure with improved abilities and advanced treatment systems. According to a report of the United Nations (2017), the size of elderly population is also expected to grow significantly in Africa, followed by North America, Latin America and the Caribbean, and Asia Pacific (APAC) by 2050.
The aging population is vastly vulnerable to various chronic conditions that may require medical interventions in multiple forms. For instance, according to a research conducted by the American Diabetes Association in 2017, the one-third of adult population in the US, aged over 65, had diabetes. Moreover, according to the study conducted by a team of researchers at the University of Catania, Italy, in 2019, in the world, the number of patients suffering with diabetes among patients above 60 years of age was 123 million in 2017, and it is expected to double by 2045. Diabetes in adults generates high demand for various regularly prescribed medicines that include tablets and capsules, whose outer covering is made up of bioresorbable materials. Further, according to the Centers for Disease Control and Prevention (CDC), in 2018, 10.1% of adults with age 18 and above were diagnosed with diabetes. A majority of these diabetic patients has been reported to consume oral medication for this condition, including capsules.
According to a new analysis published in the British Journal of Surgery (BJS) in May 2019, the number of people with age 75 and above undergoing orthopedic surgeries in England increased from 544,998 in 1999 to 1,012,517 in 2015. The increasing number of growing orthopedic surgeries implies the increase in the requirement of surgical supplies and devices, which indicate large consumption of bioresorbable materials. Thus, the growing geriatric population is projected to drive the demand for bioresorbable medical materials, which, in turn, would drive the growth of the market during 2020–2027.
Bioresorbable polymers are considered to be green materials of the future. These polymers are used in a diverse range of medical applications that include wound dressings, surgical sutures, drug delivery systems, tissue regeneration, gene delivery, tissue regeneration, tissue engineering scaffold, nanotechnology, and medical implants. The utilization of these polymers has greatly impacted the advancement of modern medicine owing to their ability to break down after serving the motive. The increasing adoption of these materials can also be attributed to their physiochemical, mechanical, and chemical properties that ensure improved functionality along with sensitivity toward the natural body stimuli.
The biodegradable plastics are also seen to be promising alternatives to commodity plastics. This has significantly boosted the production of biodegradable plastics in the recent years. According to the European BioplasticsFAO statistics, the current bioplastics production capacity has been reported to be 2.11 million tons worldwide. Such mass production in response to high demand is driving the growth of the bioresorbable medical material market.
Product Type-Based Insights
In terms of product type, the Bioresorbable Medical Material in healthcare market is segmented into polylactide (pla), poly-l-lactide (plla), poly-dl-lactide (pdlla), polyglycolide (pga), polycaprolactone (pcl) and others. the polylactide (pla) segment held the largest share of the market in 2019 however the poly-dl-lactide (pdlla) segment is anticipated to register the highest CAGR of 11.1% in the market during the forecast period.
Bioresorbable Medical Material in Healthcare Market, by Product Type – 2019 and 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Application-Based Insights
Based on application, the Bioresorbable Medical Material in healthcare market is segmented into drug delivery, medical devices, orthopedics and others. The drug delivery segment held the largest share of the market in 2019, whereas the medical devices segment is estimated to register the highest CAGR of 10.5% in the market during the forecast period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Bioresorbable Medical Material Market: Strategic Insights
Market Size Value in US$ 935.99 Million in 2019 Market Size Value by US$ 1,942.13 Million by 2027 Growth rate CAGR of 9.7% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Bioresorbable Medical Material Market: Strategic Insights
| Market Size Value in | US$ 935.99 Million in 2019 |
| Market Size Value by | US$ 1,942.13 Million by 2027 |
| Growth rate | CAGR of 9.7% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
The Bioresorbable Medical Material in healthcare market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.
Bioresorbable Medical Material in Healthcare Market – by Product Type
- Polylactide (PLA)
- Poly-L-lactide (PLLA)
- Poly-DL-lactide (PDLLA)
- Polyglycolide (PGA)
- Polycaprolactone (PCL)
- Others
Bioresorbable Medical Material in Healthcare Market – by Application
- Drug Delivery
- Medical Devices
- Orthopedics
- Others
Bioresorbable Medical Material in Healthcare Market – by Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
South America and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- Evonik
- Foster Corporation
- Poly-Med Corporation
- Zeus Industrial Products, Inc.
- Ashland
- Durect Corporation
- Groupe PCAS
- DSM
- Corbion
- Putnam Plastics
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product Type ; Application , and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Bioresorbable Medical Material Market – By Product
1.3.2 Global Bioresorbable Medical Material Market – By Application
1.3.3 Global Bioresorbable Medical Material Market – By Geography
2. Bioresorbable Medical Material Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Bioresorbable Medical Material – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America
4.2.2 Europe
4.2.3 Asia Pacific
4.2.4 Middle East & Africa
4.2.5 South and Central America
4.3 Expert Opinion
5. Bioresorbable Medical Material – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing number of orthopedic surgeries
5.1.2 Growing geriatric population
5.1.3 Rising adoption of bioresorbable polymers for medical use
5.2 Market Restraints
5.2.1 Challenges associated with the use of bioresorbable materials for medical use
5.2.2 Bassinet on the global business due to Coronavirus pandemic
5.3 Market Opportunities
5.3.1 Development of bioresorbable drug delivery systems during coronavirus outbreak
5.3.2 Diversification in medical applications of bioresorbable materials by start-ups and established players
5.4 Future Trends
5.4.1 Consistent launch of new products
5.5 Impact Analysis
6. Bioresorbable Medical Material Market – Global Analysis
6.1 Global Bioresorbable Medical Material Market Revenue Forecast and Analysis
6.2 Global Bioresorbable Medical Material Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Bioresorbable Medical Material Market Analysis – By Product Type
7.1 Overview
7.2 Bioresorbable Medical Material Market Revenue Share, by Product Type (2019 and 2027)
7.3 Polylactide (PLA)
7.3.1 Overview
7.3.2 Polylactide (PLA): Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Poly-L-lactide (PLLA)
7.4.1 Overview
7.4.2 Poly-L-lactide (PLLA): Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Poly-DL-lactide (PDLLA)
7.5.1 Overview
7.5.2 Poly-DL-lactide (PDLLA): Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (US$ Million)
7.6 Polyglycolide (PGA)
7.6.1 Overview
7.6.2 Polyglycolide (PGA): Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (US$ Million)
7.7 Polycaprolactone (PCL)
7.7.1 Overview
7.7.2 Polycaprolactone (PCL): Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (US$ Million)
8. Bioresorbable Medical Material Market – By Application
8.1 Overview
8.2 Bioresorbable Medical Material Market, by Application, 2019 and 2027 (%)
8.3 Drug Delivery
8.3.1 Overview
8.3.2 Drug Delivery: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Medical Devices
8.4.1 Overview
8.4.2 Medical Devices: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Orthopedics
8.5.1 Overview
8.5.2 Orthopedics: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (US$ Million)
9. Bioresorbable Medical Material Market – Geographic Analysis
9.1 North America: Bioresorbable Medical Material Market
9.1.1 Overview
9.1.2 North America: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.1.3 North America: Bioresorbable Medical Material Market, by Product Type, 2018–2027 (USD Million)
9.1.4 North America: Bioresorbable Medical Material Market, by Application, 2018–2027 (USD Million)
9.1.5 North America: Bioresorbable Medical Material Market, by Country, 2019 & 2027 (%)
9.1.6 US: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.1 US: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.2 US: Bioresorbable Medical Material Market, by Product Type, 2018–2027 (USD Million)
9.1.6.3 US: Bioresorbable Medical Material Market, by Application, 2018–2027 (USD Million)
9.1.7 Canada: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Canada: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Canada: Bioresorbable Medical Material Market, by Product Type, 2018–2027 (USD Million)
9.1.7.3 Canada: Bioresorbable Medical Material Market, by Application, 2018–2027 (USD Million)
9.1.8 Mexico: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.1 Mexico: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.2 Mexico: Bioresorbable Medical Material Market, by Product Type, 2018–2027 (USD Million)
9.1.8.3 Mexico: Bioresorbable Medical Material Market, by Application, 2018–2027 (USD Million)
9.2 Europe: Bioresorbable Medical Material Market
9.2.1 Overview
9.2.2 Europe: Bioresorbable Medical Material Market - Revenue and Forecast to 2027 (USD Million)
9.2.3 Europe: Bioresorbable Medical Material Market, by Product, 2018–2027 (USD Million)
9.2.4 Europe: Bioresorbable Medical Material Market, by Application, 2018–2027 (USD Million)
9.2.5 Europe: Bioresorbable Medical Material Market, by Country, 2018 & 2027 (%)
9.2.6 Germany: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.2.6.1 Germany: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.2.6.2 Germany: Bioresorbable Medical Material Market, by Product, 2018–2027 (USD Million)
9.2.6.3 Germany: Bioresorbable Medical Material Market, by Application, 2018–2027 (USD Million)
9.2.7 UK: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.2.7.1 UK: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.2.7.2 United Kingdom: Bioresorbable Medical Material Market, by Product, 2018–2027 (USD Million)
9.2.7.3 United Kingdom: Bioresorbable Medical Material Market, by Application, 2018–2027 (USD Million)
9.2.8 France: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.2.8.1 France: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.2.8.2 France: Bioresorbable Medical Material Market, by Product Type, 2018–2027 (USD Million)
9.2.8.3 France: Bioresorbable Medical Material Market, by Application, 2018–2027 (USD Million)
9.2.9 Spain: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.2.9.1 Spain: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.2.9.2 Spain: Bioresorbable Medical Material Market, by Product Type, 2018–2027 (USD Million)
9.2.9.3 Spain: Bioresorbable Medical Material Market, by Application, 2018–2027 (USD Million)
9.2.10 Italy: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.2.10.1 Italy: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.2.10.2 Italy: Bioresorbable Medical Material Market, by Product Type, 2018–2027 (USD Million)
9.2.10.3 Italy: Bioresorbable Medical Material Market, by Application,2018–2027 (USD Million)
9.3 Asia Pacific: Bioresorbable Medical Material Market
9.3.1 Overview
9.3.2 Asia Pacific: Bioresorbable Medical Material Market - Revenue and Forecast to 2027 (USD Million)
9.3.3 Asia Pacific: Bioresorbable Medical Material Market, by Product Type, 2018–2027 (USD Million)
9.3.4 Asia Pacific: Bioresorbable Medical Material Market, by Application, 2018–2027 (USD Million)
9.3.5 Asia Pacific: Bioresorbable Medical Material Market, by Country, 2018 & 2027 (%)
9.3.6 China: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.3.6.1 China: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.3.6.2 China: Bioresorbable Medical Material Market, by Product Type, 2018–2027 (USD Million)
9.3.6.3 China: Bioresorbable Medical Material Market, by Application, 2018–2027 (USD Million)
9.3.7 Japan: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.3.7.1 Japan: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.3.7.2 Japan: Bioresorbable Medical Material Market, by Product Type, 2018–2027 (USD Million)
9.3.7.3 Japan: Bioresorbable Medical Material Market, by Application, 2018–2027 (USD Million)
9.3.8 India: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.3.8.1 India: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.3.8.2 India: Bioresorbable Medical Material Market, by Product Type, 2018–2027 (USD Million)
9.3.8.3 India: Bioresorbable Medical Material Market, by Application, 2018–2027 (USD Million)
9.3.9 South Korea: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.3.9.1 South Korea: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.3.9.2 South Korea: Bioresorbable Medical Material Market, by Product Type, 2018–2027 (USD Million)
9.3.9.3 South Korea: Bioresorbable Medical Material Market, by Application, 2018–2027 (USD Million)
9.3.10 Australia: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.3.10.1 Australia: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.3.10.2 Australia: Bioresorbable Medical Material Market, by Product Type, 2018–2027 (USD Million)
9.3.10.3 Australia: Bioresorbable Medical Material Market, by Application, 2018–2027 (USD Million)
9.4 Middle East & Africa: Bioresorbable Medical Material Market
9.4.1 Overview
9.4.2 Middle East & Africa: Bioresorbable Medical Material Market - Revenue and Forecast to 2027 (USD Million)
9.4.3 Middle East and Africa: Bioresorbable Medical Material Market, by Product Type, 2018–2027 (USD Million)
9.4.4 Middle East and Africa: Bioresorbable Medical Material Market, by Application, 2018–2027 (USD Million)
9.4.5 Middle East & Africa: Bioresorbable Medical Material Market Share by Country – 2019 & 2027, (%)
9.4.6 Saudi Arabia: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.4.6.1 Saudi Arabia: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.4.6.2 Saudi Arabia: Bioresorbable Medical Material Market, by Product Type, 2018–2027 (USD Million)
9.4.6.3 Saudi Arabia: Bioresorbable Medical Material Market, by Application, 2018–2027 (USD Million)
9.4.7 UAE: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.4.7.1 UAE: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.4.7.2 UAE: Bioresorbable Medical Material Market, by Product Type, 2018–2027 (USD Million)
9.4.7.3 UAE: Bioresorbable Medical Material Market, by Application, 2018–2027 (USD Million)
9.4.8 South Africa: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (US$ Million)
9.4.8.1 South Africa: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.4.8.2 South Africa: Bioresorbable Medical Material Market, by Product Type, 2018–2027 (USD Million)
9.4.8.3 South Africa: Bioresorbable Medical Material Market, by Application, 2018–2027 (USD Million)
9.5 South and Central America: Bioresorbable Medical Material Market
9.5.1 Overview
9.5.2 South and Central America: Bioresorbable Medical Material Market - Revenue and Forecast to 2027 (US$ Million)
9.5.3 South and Central America: Bioresorbable Medical Material Market, by Product Type, 2018–2027 (USD Million)
9.5.4 South and Central America: Bioresorbable Medical Material Market, by Application, 2018–2027 (USD Million)
9.5.5 South and Central America: Bioresorbable Medical Material Market, by Country, 2018 & 2027 (%)
9.5.6 Brazil: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.5.6.1 Brazil: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.5.6.2 Brazil: Bioresorbable Medical Material Market, by Product Type, 2018–2027 (USD Million)
9.5.6.3 Brazil: Bioresorbable Medical Material Market, by Application, 2018–2027 (USD Million)
9.5.7 Argentina: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.5.7.1 Argentina: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
9.5.7.2 Argentina: Bioresorbable Medical Material Market, by Product Type, 2018–2027 (USD Million)
9.5.7.3 Argentina: Bioresorbable Medical Material Market, by Application, 2018–2027 (USD Million)
10. Bioresorbable Medical Material Market– Industry Landscape
10.1 Overview
10.1.1 Recent Developments by Players in Bioresorbable Medical Material Market
11. Bioresorbable Medical Material Market – Key Company Profiles
11.1 Evonik
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Foster Corporation
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Poly-Med Incorporated
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Zeus Industrial Products, Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Ashland
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Durect Corporation
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Groupe PCAS
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 DSM
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Corbion
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Putnam Plastics
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Bioresorbable Medical Material Market, by Product Type– Revenue and Forecast to 2027 (USD Million)
Table 2. North America Bioresorbable Medical Material Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 3. US Bioresorbable Medical Material Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 4. US Bioresorbable Medical Material Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 5. Canada Bioresorbable Medical Material Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 6. Canada Bioresorbable Medical Material Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 7. Mexico Bioresorbable Medical Material Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 8. Mexico Bioresorbable Medical Material Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 9. Europe Bioresorbable Medical Material Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 10. Europe Bioresorbable Medical Material Market, by Application Revenue and Forecast to 2027 (USD Million)
Table 11. Germany Bioresorbable Medical Material Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 12. Germany Bioresorbable Medical Material Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 13. UK Bioresorbable Medical Material Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 14. UK Bioresorbable Medical Material Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 15. France Bioresorbable Medical Material Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 16. France Bioresorbable Medical Material Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 17. Spain Bioresorbable Medical Material Market, by Product Type– Revenue and Forecast to 2027 (USD Million)
Table 18. Spain Bioresorbable Medical Material Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 19. Italy Bioresorbable Medical Material Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 20. Italy Bioresorbable Medical Material Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 21. Asia Pacific Bioresorbable Medical Material Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 22. Asia Pacific Bioresorbable Medical Material Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 23. China Bioresorbable Medical Material Market, by Product Type– Revenue and Forecast to 2027 (USD Million)
Table 24. China Bioresorbable Medical Material Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 25. Japan Bioresorbable Medical Material Market, by Product Type– Revenue and Forecast to 2027 (USD Million)
Table 26. Japan Bioresorbable Medical Material Market, by Application, – Revenue and Forecast to 2027 (USD Million)
Table 27. India Bioresorbable Medical Material Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 28. India Bioresorbable Medical Material Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 29. South Korea Bioresorbable Medical Material Market, by Product Type– Revenue and Forecast to 2027 (USD Million)
Table 30. South Korea Bioresorbable Medical Material Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 31. Australia Bioresorbable Medical Material Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 32. Australia Bioresorbable Medical Material Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 33. Middle East and Africa Bioresorbable Medical Material Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 34. Middle East and Africa Bioresorbable Medical Material Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 35. Saudi Arabia Bioresorbable Medical Material Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 36. Saudi Arabia Bioresorbable Medical Material Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 37. UAE Bioresorbable Medical Material Market, by Product Type– Revenue and Forecast to 2027 (USD Million)
Table 38. UAE Bioresorbable Medical Material Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 39. South Africa Bioresorbable Medical Material Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 40. South Africa Bioresorbable Medical Material Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 41. South and Central America Bioresorbable Medical Material Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 42. South and Central America Bioresorbable Medical Material Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 43. Brazil Bioresorbable Medical Material Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 44. Brazil Bioresorbable Medical Material Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 45. Argentina Bioresorbable Medical Material Market, by Product Type– Revenue and Forecast to 2027 (USD Million)
Table 46. Argentina Bioresorbable Medical Material Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 47. Recent Developments in THE Bioresorbable Medical Material Market
Table 48. Glossary of Terms, Bioresorbable Medical Material Market
LIST OF FIGURES
Figure 1. Bioresorbable Medical Material Market Segmentation
Figure 2. Bioresorbable Medical Material Segmentation, By Region
Figure 3. Global Bioresorbable Medical Material Market Overview
Figure 4. Polylactide (PLA) Segment Held Largest Share of Product Type Segment In Bioresorbable Medical Material Market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Bioresorbable Medical Material Market, By Geography (US$ Million)
Figure 7. Global Bioresorbable Medical Material Market- Leading Country Markets (US$ Million)
Figure 8. North America PEST Analysis
Figure 9. Europe: PEST Analysis
Figure 10. Asia Pacific PEST Analysis
Figure 11. Middle East & Africa PEST Analysis
Figure 12. South and Central America PEST Analysis
Figure 13. Bioresorbable Medical Material Market Impact Analysis of Drivers and Restraints
Figure 14. Global Bioresorbable Medical Material Market – Revenue Forecast and Analysis – 2019- 2027
Figure 15. Global Bioresorbable Medical Material Market – By Geography Forecast And Analysis – 2019- 2027
Figure 16. Market Positioning Of Key Players In Global Bioresorbable Medical Material Market
Figure 17. Bioresorbable Medical Material Market Revenue Share, by Product Type (2019 and 2027)
Figure 18. Polylactide (PLA): Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (US$ Million)
Figure 19. Poly-L-lactide (PLLA): Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Poly-DL-lactide (PDLLA): Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Polyglycolide (PGA): Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Polycaprolactone (PCL): Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Others: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Bioresorbable Medical Material Market, by Application, 2019 and 2027 (%)
Figure 25. Drug Delivery: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (US$ Million)
Figure 26. Medical Devices: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (US$ Million)
Figure 27. Orthopedics: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (US$ Million)
Figure 28. Others: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (US$ Million)
Figure 29. North America: Bioresorbable Medical Material Market, by Key Country – Revenue (2019) (USD Million)
Figure 30. North America Bioresorbable Medical Material Market Revenue and Forecast to 2027 (USD Million)
Figure 31. North America: Bioresorbable Medical Material Market, by Country, 2019 & 2027 (%)
Figure 32. US: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
Figure 33. Canada: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
Figure 34. Mexico: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
Figure 35. Europe: Bioresorbable Medical Material Market, by Key Country – Revenue (2019) (USD Million)
Figure 36. Europe Bioresorbable Medical Material Market Revenue and Forecast to 2027 (USD Million)
Figure 37. Europe: Bioresorbable Medical Material Market, by Country, 2018 & 2027 (%)
Figure 38. Germany: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
Figure 39. UK: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
Figure 40. France: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
Figure 41. Spain: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
Figure 42. Italy: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
Figure 43. Asia Pacific: Bioresorbable Medical Material Market, by Key Country – Revenue (2019) (USD Million)
Figure 44. Asia Pacific Bioresorbable Medical Material Market Revenue and Forecast to 2027 (USD Million)
Figure 45. China: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
Figure 46. Japan: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
Figure 47. India: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
Figure 48. South Korea: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
Figure 49. Australia: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
Figure 50. Middle East & Africa: Bioresorbable Medical Material Market, by Key Country – Revenue (2019) (USD Million)
Figure 51. Middle East & Africa Bioresorbable Medical Material Market Revenue and Forecast to 2027 (USD Million)
Figure 52. Middle East & Africa: Bioresorbable Medical Material Market Share by Country – 2019 & 2027, (%)
Figure 53. Saudi Arabia: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
Figure 54. UAE: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (US$ Million)
Figure 55. South Africa: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
Figure 56. South and Central America: Bioresorbable Medical Material Market, by Key Country – Revenue (2019) (USD Million)
Figure 57. South and Central America Bioresorbable Medical Material Market Revenue and Forecast to 2027 (USD Million)
Figure 58. South and Central America: Bioresorbable Medical Material Market, by Country, 2018 & 2027 (%)
Figure 59. Brazil: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
Figure 60. Argentina: Bioresorbable Medical Material Market – Revenue and Forecast to 2027 (USD Million)
The List of Companies – Global Bioresorbable Medical Material Market
- Evonik.
- Foster Corporation
- Poly-Med Corporation
- Zeus Industrial Products, Inc.
- Ashland
- Durect Corporation
- Groupe PCAS
- DSM
- Corbion
- Putnam Plastics
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Bioresorbable Medical Material Market
Mar 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Mar 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Mar 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Mar 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Mar 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)